Dalzanemdor (SAGE-718) Awarded Innovation Passport Designation for Cognitive Impairment Associated with Huntington’s Disease and Entry into the Innovative Licensing and Access Pathway by the U.K. Medi...

Sample article from our Health Care Sector

January 31, 2024 (press release) –

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) launched the Innovative Licensing and Access Pathway (ILAP) with the goal to accelerate the development and time to market for medicines. The ILAP Steering Group awarded an Innovative Passport Designation to dalzanemdor (SAGE-718) for cognitive impairment associated with Huntington’s Disease (HD).

Dalzanemdor (SAGE-718) is an investigational NMDA receptor positive allosteric modulator (PAM) being studied as a potential treatment for cognitive impairment associated with certain neurodegenerative diseases, including HD.

Innovation Passport Designation supports enhanced coordination of development activities, including access to a range of development tools and other potential benefits. Eligibility for the designation is based on a set of criteria including the potential to treat a life-threatening or serious condition for which there is significant unmet need. ILAP does not necessarily lead to a faster development pathway or regulatory review process, and does not increase the likelihood of regulatory approval. More information can be found on the ILAP website.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

More from our Health Care Sector Coverage
See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.